Literature DB >> 9916793

Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease.

P G Kehoe, C Russ, S McIlory, H Williams, P Holmans, C Holmes, D Liolitsa, D Vahidassr, J Powell, B McGleenon, M Liddell, R Plomin, K Dynan, N Williams, J Neal, N J Cairns, G Wilcock, P Passmore, S Lovestone, J Williams, M J Owen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9916793     DOI： 10.1038/5009

Source DB:  PubMed          Journal:  Nat Genet        ISSN： 1061-4036            Impact factor:   38.330


× No keyword cloud information.
  57 in total

1.  Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor.

Authors:  Matthew L Hemming; Dennis J Selkoe
Journal:  J Biol Chem       Date:  2005-09-09       Impact factor: 5.157

Review 2.  Biomarkers related to aging in human populations.

Authors:  Eileen Crimmins; Sarinnapha Vasunilashorn; Jung Ki Kim; Dawn Alley
Journal:  Adv Clin Chem       Date:  2008       Impact factor: 5.394

Review 3.  Targeting amyloid clearance in Alzheimer's disease as a therapeutic strategy.

Authors:  Natalia N Nalivaeva; Anthony J Turner
Journal:  Br J Pharmacol       Date:  2019-03-11       Impact factor: 8.739

Review 4.  Genetics and underlying pathology of dementia.

Authors:  Beata Ferencz; Lotte Gerritsen
Journal:  Neuropsychol Rev       Date:  2015-01-08       Impact factor: 7.444

5.  Angiotensin I converting enzyme polymorphism effects in patients with normal pressure hydrocephalus syndrome before and after surgery.

Authors:  Maria del Mar Matarín; Maria Antonia Poca; David Bartrés-Faz; Maria Mataró; Imma C Clemente; Cristina Solé-Padullés; Emili González-Pérez; Pedro Moral; Maite Barrios; Carme Junqué; Juan Sahuquillo
Journal:  J Neurol       Date:  2005-02       Impact factor: 4.849

6.  Phosphorylation of amyloid-β peptide at serine 8 attenuates its clearance via insulin-degrading and angiotensin-converting enzymes.

Authors:  Sathish Kumar; Sandesh Singh; Désirée Hinze; Michaele Josten; Hans-Georg Sahl; Martin Siepmann; Jochen Walter
Journal:  J Biol Chem       Date:  2012-01-20       Impact factor: 5.157

7.  Sequence variation in the proximity of IDE may impact age at onset of both Parkinson disease and Alzheimer disease.

Authors:  Mia E-L Blomqvist; Peter A Silburn; Daniel D Buchanan; Niels Andreasen; Kaj Blennow; Nancy L Pedersen; Anthony J Brookes; George D Mellick; Jonathan A Prince
Journal:  Neurogenetics       Date:  2004-04-16       Impact factor: 2.660

8.  Abeta42-to-Abeta40- and angiotensin-converting activities in different domains of angiotensin-converting enzyme.

Authors:  Kun Zou; Tomoji Maeda; Atsushi Watanabe; Junjun Liu; Shuyu Liu; Ryutaro Oba; Yoh-ichi Satoh; Hiroto Komano; Makoto Michikawa
Journal:  J Biol Chem       Date:  2009-09-22       Impact factor: 5.157

9.  Angiotensin-converting enzyme levels and activity in Alzheimer's disease: differences in brain and CSF ACE and association with ACE1 genotypes.

Authors:  Scott Miners; Emma Ashby; Shabnam Baig; Rachel Harrison; Hannah Tayler; Elizabeth Speedy; Jonathan A Prince; Seth Love; Patrick G Kehoe
Journal:  Am J Transl Res       Date:  2009-01-18       Impact factor: 4.060

Review 10.  Endothelin-converting enzymes and related metalloproteases in Alzheimer's disease.

Authors:  Javier Pacheco-Quinto; Aimee Herdt; Christopher B Eckman; Elizabeth A Eckman
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.